membrane vesicles. However, the presence of this secreted tau does not result in cell death. Conclusion: We conclude that extracellular tau could arise by two different ways, by cell death or by secretion through membrane vesicles. Copyright © 2012 S. Karger AG, Basel Tauopathies are different CNS disorders characterized by the presence of hyperphosphorylated and aggregated tau protein, with Alzheimer's disease being the most common tauopathy. In Alzheimer's disease, tau pathology follows a reproducible pattern, starting first in the entorhinal cortex and hippocampus and from there the disease spreads to the cortex [1] . In other tauopathies, such as the progressive supranuclear palsy [2] or in argyrophilic grain disease, a similar spread from one brain region to another has been reported. For example in argyrophilic grain disease, the pathological process starts at the ambient gyrus, and from there it extends to the temporal lobe, septum, insular cortex and cingulate gyrus [3] . This manner of tau pathology spreading has suggested the possibility of an intercellular transfer of tau
protein [4, 5] . The finding of the presence of tau in the extracellular space in vivo, such as in cerebrospinal fluid [6] and in brain interstitial fluid [7] , further supports the idea of tau propagation. Moreover, the cerebrospinal fluid levels of tau may provide a useful biomarker to distinguish the different subgroups of Alzheimer's disease patients [8] . Two hypotheses have been described to explain the spreading of tau pathology. The first one indicates that, in the neurodegenerative process, neuronal death takes place and intracellular tau can be released to the extracellular space. This extracellular tau can be toxic for neighboring cells [4] . The other hypothesis suggests that the intercellular propagation of tau occurs via an exocytic/endocytic process [9, 10] . Tau spreading should occur only in pathological conditions since no secretion of tau protein has been found, for example, in cultured cortical neurons [11] .
Thus, a possibility is that aberrant overexpression of tau protein could favor the secretion of the excess of protein tau. To test that, we have analyzed the expression of different amounts of tau protein in non-neuronal cells. Our results demonstrate that tau secretion takes place when tau is overexpressed and that the secretion is, at least in part, through membrane vesicles.
Addition of Tau Protein to Cultured Neuronal Cells Results in Neuronal Death and Release of Tau to the Extracellular Space
In a previous report, we have described that addition of tau protein to cultured neuronal cells results in its interaction with cell receptors [12] followed by an increase in intracellular calcium concentration and cell death [4] . To test that intracellular tau is released to the extracellular space upon cell death, we have added a variant of tau protein lacking a part of its N-terminal region as a toxic agent, to cultured neuronal cells. In these cultures, we have looked for the presence, in the extracellular space, of intracellular tau that contains the whole molecule of tau including the N-terminal region. This Nterminal region could be identified by a specific antibody [5] . Thus, tau could be released into the extracellular space as a consequence of neuronal death. Different agents, including the presence of already released extracellular tau, could promote this neuronal death. However, there could be other forms for extracellular tau that could arise independent of cell death. Thus, we tested for another possible alternative way to generate extracellular tau. 
Overexpression of Tau Protein Results in Its Secretion through Membrane Vesicles
Non-neuronal cells (COS-7) were transfected with increasing amounts of tau constructs to raise levels of tau protein, without affecting cell viability [13] . Figure 1 shows that, above a threshold level of expression, tau protein could be found in the extracellular space. Furthermore, when we isolated the membrane vesicles from the culture medium of these cells [14] , the presence of tau protein was observed in this vesicles fraction ( fig. 1 ) . Indeed, the inhibition of vesicle secretion reduced the presence of tau in the extracellular space (data not shown).
In contrast to the results found with purified, naked, tau protein, vesicles containing tau protein do not promote cell death. Thus, there are at least two different mechanisms to release intracellular tau to the extracellular space. In one, the release is a consequence of neuronal death. This released tau could be toxic and could induce further cell death. This explains a way to spread tau pathology. The other mechanism for the secretion of tau in association with membrane vesicles seems to be less toxic and further studies should be done to test if it plays any role in the spreading of tau pathology. The release of tau through membrane vesicles may occur in a similar fashion to that reported for ␣ -synuclein [15] . On the other hand, less is known about the release of intracellular aggregated tau.
Secretion of those aggregates through membrane vesicles has been suggested [9] . However, other possible mechanisms cannot be excluded. Recently, a way to propagate SOD1 aggregates has been indicated in a prion-like manner. These aggregates, without being inside membrane vesicles, penetrate inside cells by macropinocytosis and they can be released again to the extracellular medium [16] . In summary, the main conclusion of the present communication is that an excess of intracellular tau could be corrected safely by the release of tau through membrane vesicles.
